APP Pharmaceuticals on Its Own After Abraxis Break-Up

APP Pharmaceuticals Inc. officially became a separate, publicly traded Schaumburg-based company as the result of the split-up of the Los Angeles biotech concern known as Abraxis BioScience Inc.
Chicago Tribune